NNVC (Nanoviricides) Cyclically Adjusted FCF per Share: $-1.53 (As of Mar. 2026)


NNVC Nanoviricides Inc NNVC
35 GF Score
Price $1.47
View Full Analysis

What is Nanoviricides Cyclically Adjusted FCF per Share?

Nanoviricides NNVC -2.00% 35 Cyclically Adjusted FCF per Share is $-1.53 as of Mar. 2026. GuruFocus rates NNVC with a GF Score™ of 35/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nanoviricides's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.089. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-1.53 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Nanoviricides was 15.60% per year. The lowest was -3.70% per year. And the median was 0.75% per year.

As of today (2026-07-08), Nanoviricides's current stock price is $1.47. Nanoviricides's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-1.53. Nanoviricides's Cyclically Adjusted Price-to-FCF of today is .


Nanoviricides  (AMEX:NNVC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nanoviricides Cyclically Adjusted FCF per Share Related Terms


Nanoviricides Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Nanoviricides's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoviricides Cyclically Adjusted FCF per Share Chart

Nanoviricides Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.83 -2.89 -2.69 -2.23 -1.74

Nanoviricides Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.83 -1.74 -1.67 -1.62 -1.53

NNVC vs LSTA, SGMO, LITS: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Nanoviricides's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanoviricides Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoviricides's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nanoviricides's Cyclically Adjusted Price-to-FCF falls into.


NNVC
35GF Score
Nanoviricides Inc NNVC
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoviricides Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nanoviricides's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.089/330.2130*330.2130
=-0.089

Current CPI (Mar. 2026) = 330.2130.

Nanoviricides Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.495 241.018 -0.678
201609 -0.773 241.428 -1.057
201612 -0.897 241.432 -1.227
201703 -0.704 243.801 -0.954
201706 -0.335 244.955 -0.452
201709 -0.501 246.819 -0.670
201712 -0.463 246.524 -0.620
201803 -0.446 249.554 -0.590
201806 -1.025 251.989 -1.343
201809 -0.289 252.439 -0.378
201812 -0.628 251.233 -0.825
201903 -0.561 254.202 -0.729
201906 -0.438 256.143 -0.565
201909 -0.374 256.759 -0.481
201912 -0.292 256.974 -0.375
202003 -0.368 258.115 -0.471
202006 -0.207 257.797 -0.265
202009 -0.217 260.280 -0.275
202012 -0.218 260.474 -0.276
202103 -0.141 264.877 -0.176
202106 -0.201 271.696 -0.244
202109 -0.065 274.310 -0.078
202112 -0.199 278.802 -0.236
202203 -0.147 287.504 -0.169
202206 -0.127 296.311 -0.142
202209 -0.093 296.808 -0.103
202212 -0.125 296.797 -0.139
202303 -0.154 301.836 -0.168
202306 -0.129 305.109 -0.140
202309 -0.101 307.789 -0.108
202312 -0.147 306.746 -0.158
202403 -0.169 312.332 -0.179
202406 -0.129 314.175 -0.136
202409 -0.193 315.301 -0.202
202412 -0.150 315.605 -0.157
202503 -0.124 319.799 -0.128
202506 -0.105 322.561 -0.107
202509 -0.098 324.800 -0.100
202512 -0.103 324.054 -0.105
202603 -0.089 330.213 -0.089

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-1.53 mean?
Nanoviricides (NNVC) has a Cyclically Adjusted FCF per Share of $-1.53 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nanoviricides and its competitors.
Is Nanoviricides' Cyclically Adjusted FCF per Share too high?
Nanoviricides' current Cyclically Adjusted FCF per Share is $-1.53. Overall, Nanoviricides has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Cyclically Adjusted FCF per Share compare to LSTA and SGMO?
Nanoviricides' Cyclically Adjusted FCF per Share of $-1.53 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nanoviricides and its competitors. Nanoviricides's current Cyclically Adjusted FCF per Share is $-1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (NNVC) has a current Cyclically Adjusted FCF per Share of $-1.53. The current Cyclically Adjusted FCF per Share is $-1.53. Nanoviricides' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Nanoviricides (NNVC), the current Cyclically Adjusted FCF per Share is $-1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanoviricides Business Description

Other Exchanges NV3P:Germany
Address 1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
35GF Score

Get the complete analysis for NNVC

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.47
Price